FPGS
Basic information
Region (hg38): 9:127794597-127814494
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FPGS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 1 | 1 |
Variants in FPGS
This is a list of pathogenic ClinVar variants found in the FPGS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-127802935-C-T | not specified | Uncertain significance (May 06, 2022) | ||
9-127802937-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
9-127802943-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
9-127802952-G-T | not specified | Uncertain significance (Sep 11, 2024) | ||
9-127802979-G-C | not specified | Likely benign (Aug 19, 2024) | ||
9-127802988-A-G | Benign (Oct 29, 2020) | |||
9-127803001-T-G | not specified | Uncertain significance (Jul 14, 2021) | ||
9-127803012-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
9-127803013-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
9-127804295-G-A | not specified | Uncertain significance (Jun 21, 2023) | ||
9-127804349-A-C | not specified | Uncertain significance (Dec 09, 2023) | ||
9-127804382-T-C | not specified | Uncertain significance (Jan 30, 2024) | ||
9-127804639-T-A | not specified | Uncertain significance (Nov 13, 2024) | ||
9-127804655-C-T | not specified | Uncertain significance (Mar 03, 2022) | ||
9-127804688-C-T | not specified | Uncertain significance (Jun 05, 2024) | ||
9-127807242-C-T | not specified | Uncertain significance (Nov 24, 2024) | ||
9-127807269-G-A | not specified | Uncertain significance (Dec 03, 2024) | ||
9-127807275-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
9-127807443-T-C | not specified | Uncertain significance (Oct 22, 2024) | ||
9-127808301-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
9-127808581-G-A | not specified | Uncertain significance (Aug 04, 2024) | ||
9-127808610-C-G | not specified | Uncertain significance (Nov 25, 2024) | ||
9-127808825-G-C | not specified | Uncertain significance (Jan 17, 2024) | ||
9-127808836-T-C | not specified | Uncertain significance (Feb 06, 2024) | ||
9-127809726-G-A | not specified | Uncertain significance (Oct 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FPGS | protein_coding | protein_coding | ENST00000373247 | 15 | 19731 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000116 | 0.998 | 125718 | 0 | 30 | 125748 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.89 | 239 | 337 | 0.710 | 0.0000207 | 3684 |
Missense in Polyphen | 43 | 90.364 | 0.47585 | 989 | ||
Synonymous | 0.624 | 141 | 151 | 0.935 | 0.00000948 | 1247 |
Loss of Function | 2.68 | 15 | 31.1 | 0.482 | 0.00000164 | 322 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000158 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000968 | 0.0000924 |
European (Non-Finnish) | 0.000153 | 0.000149 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000348 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes conversion of folates to polyglutamate derivatives allowing concentration of folate compounds in the cell and the intracellular retention of these cofactors, which are important substrates for most of the folate-dependent enzymes that are involved in one-carbon transfer reactions involved in purine, pyrimidine and amino acid synthesis. Unsubstituted reduced folates are the preferred substrates. Metabolizes methotrexate (MTX) to polyglutamates. {ECO:0000269|PubMed:8408018, ECO:0000269|PubMed:8408019, ECO:0000269|PubMed:8408021, ECO:0000269|PubMed:8662720}.;
- Pathway
- Fluoropyrimidine Pathway, Pharmacodynamics;Folate biosynthesis - Homo sapiens (human);Methotrexate Pathway (Cancer Cell), Pharmacodynamics;Folate malabsorption, hereditary;Methylenetetrahydrofolate Reductase Deficiency (MTHFRD);Methotrexate Action Pathway;Folate Metabolism;Fluoropyrimidine Activity;folate polyglutamylation;Folate metabolism;Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B9 (folate) metabolism
(Consensus)
Recessive Scores
- pRec
- 0.270
Intolerance Scores
- loftool
- 0.742
- rvis_EVS
- -0.53
- rvis_percentile_EVS
- 20.7
Haploinsufficiency Scores
- pHI
- 0.0868
- hipred
- Y
- hipred_score
- 0.515
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.865
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fpgs
- Phenotype
- growth/size/body region phenotype;
Gene ontology
- Biological process
- liver development;nucleobase-containing compound metabolic process;glutamate metabolic process;one-carbon metabolic process;folic acid-containing compound metabolic process;brain development;animal organ regeneration;folic acid metabolic process;tetrahydrofolylpolyglutamate biosynthetic process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial inner membrane;mitochondrial matrix;cytosol
- Molecular function
- tetrahydrofolylpolyglutamate synthase activity;ATP binding;metal ion binding